University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Generalization of Extinction Learning

Phase 1

Completed

Conditions: Social Anxiety Disorder

Interventions: Drug: intranasal placebo
Drug: Scopolamine

First Posted Date: 2013-07-16

Last Posted Date: 2019-10-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT01900301

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Phase 2

Completed

Conditions: Polycystic Ovary Syndrome (PCOS)

Interventions: Other: Placebo
Drug: Flutamide

First Posted Date: 2013-06-28

Last Posted Date: 2024-05-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 45

Registration Number: NCT01889199

Locations: 🇺🇸
UCaliforniaLA, Los Angeles, California, United States

Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings

Not Applicable

Completed

Conditions: Substance Use Disorders
Mental Illness

Interventions: Behavioral: SBIRT
Behavioral: Health Education

First Posted Date: 2013-06-21

Last Posted Date: 2018-11-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1080

Registration Number: NCT01883791

Locations: 🇺🇸
UCLA Inpatient and Outpatient Psychiatric Units, Los Angeles, California, United States
🇺🇸
Ventura County Behavioral Health, Oxnard, California, United States

Cell Phone Technology Targeting ART Adherence and Drug Use

Not Applicable

Completed

Conditions: HIV
Opioid Abuse

Interventions: Behavioral: Standard Care
Behavioral: Text Messaging CBT (TXT-CBT)

First Posted Date: 2013-06-21

Last Posted Date: 2022-04-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 62

Registration Number: NCT01884233

Locations: 🇺🇸
UCLA Isap Ocrc, Los Angeles, California, United States

Pain Management in ED for Incision and Drainage of Abscess

Phase 4

Withdrawn

Conditions: Abscess

Interventions: Drug: Normal Saline
Drug: Fentanyl

First Posted Date: 2013-06-20

Last Posted Date: 2013-06-20

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01881997

Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)

Not Applicable

Completed

Conditions: Children at Risk for ASD

Interventions: Behavioral: Standard Baby Classroom
Behavioral: Baby JASPER

First Posted Date: 2013-06-11

Last Posted Date: 2018-10-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 110

Registration Number: NCT01874327

Locations: 🇺🇸
UCLA Semel Institue, Los Angeles, California, United States

Cannabis Effects on Brain Morphology in Aging

Completed

Conditions: Study Focuses on Brain Morphology and Cognition in Older Subjects

First Posted Date: 2013-06-11

Last Posted Date: 2020-11-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT01874886

Locations: 🇺🇸
UCLA Semel/Resnick Neuropsychiatric Institute, Los Angeles, California, United States

Perineal Self-Acupressure

Not Applicable

Completed

Conditions: Chronic Constipation
Hemorrhoids
Constipation

Interventions: Behavioral: Perineal Self-Acupressure
Behavioral: Educational Control

First Posted Date: 2013-06-04

Last Posted Date: 2016-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 100

Registration Number: NCT01867944

Locations: 🇺🇸
UCLA Center for East-West Medicine, Los Angeles, California, United States

Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora

Phase 2

Completed

Conditions: Bifidobacteria
Healthy Volunteers

Interventions: Dietary Supplement: Placebo (Maltodextrin)
Dietary Supplement: Xylooligosarcharide 2.8g
Dietary Supplement: Xylooligosarcharide 1.4g

First Posted Date: 2013-05-24

Last Posted Date: 2016-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT01861964

Locations: 🇺🇸
UCLA Center for Human Nutriiton, Los Angeles, California, United States
🇺🇸
UCLA Center for Human Nutrition, David Geffen School of Medicine, Los Angeles, California, United States

Trial of Ibudilast for Methamphetamine Dependence

Phase 2

Completed

Conditions: HIV Infection
Methamphetamine Dependence

Interventions: Drug: Placebo
Drug: Ibudilast

First Posted Date: 2013-05-23

Last Posted Date: 2019-01-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 125

Registration Number: NCT01860807

Locations: 🇺🇸
UCLA Vine Street Clinic, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy